APA

Croyal M., Tran T., Blanchard R. H., Le Bail J., Villard E. F., Poirier B., Aguesse A., Billon-Crossouard S., Ramin-Mangata S., Blanchard V., Nativel B., Chemello K., Khantalin I., Thedrez A., Janiak P., Krempf M., Boixel C., Lambert G. & Guillot E. (20190627). PCSK9 inhibition with alirocumab reduces lipoprotein(a) levels in nonhuman primates by lowering apolipoprotein(a) production rate. : Clinical science (London, England : 1979).

Chicago

Croyal Mikaël, Tran Thi-Thu-Trang, Blanchard Rose Hélène, Le Bail Jean-Christophe, Villard Elise F, Poirier Bruno, Aguesse Audrey, Billon-Crossouard Stéphanie, Ramin-Mangata Stéphane, Blanchard Valentin, Nativel Brice, Chemello Kévin, Khantalin Ilya, Thedrez Aurélie, Janiak Philip, Krempf Michel, Boixel Christophe, Lambert Gilles and Guillot Etienne. 20190627. PCSK9 inhibition with alirocumab reduces lipoprotein(a) levels in nonhuman primates by lowering apolipoprotein(a) production rate. : Clinical science (London, England : 1979).

Harvard

Croyal M., Tran T., Blanchard R. H., Le Bail J., Villard E. F., Poirier B., Aguesse A., Billon-Crossouard S., Ramin-Mangata S., Blanchard V., Nativel B., Chemello K., Khantalin I., Thedrez A., Janiak P., Krempf M., Boixel C., Lambert G. and Guillot E. (20190627). PCSK9 inhibition with alirocumab reduces lipoprotein(a) levels in nonhuman primates by lowering apolipoprotein(a) production rate. : Clinical science (London, England : 1979).

MLA

Croyal Mikaël, Tran Thi-Thu-Trang, Blanchard Rose Hélène, Le Bail Jean-Christophe, Villard Elise F, Poirier Bruno, Aguesse Audrey, Billon-Crossouard Stéphanie, Ramin-Mangata Stéphane, Blanchard Valentin, Nativel Brice, Chemello Kévin, Khantalin Ilya, Thedrez Aurélie, Janiak Philip, Krempf Michel, Boixel Christophe, Lambert Gilles and Guillot Etienne. PCSK9 inhibition with alirocumab reduces lipoprotein(a) levels in nonhuman primates by lowering apolipoprotein(a) production rate. : Clinical science (London, England : 1979). 20190627.